Clinical Trials Sponsored by AurKa Pharma Inc.
Total 2359 results
-
Shanghai YingLi Pharmaceutical Co. Ltd.Yingli Pharma US, IncRecruitingAdvanced Solid TumorUnited States
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingMyeloid Malignancy | Relapsed/Refractory Acute Myeloid LeukaemiaChina
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.Completed
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedMultiple MyelomaUnited States
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaChina
-
4D pharma plcICON plc; Labcorp Drug Development IncWithdrawnIdiopathic Parkinson Disease
-
MEDA Pharma GmbH & Co. KGORION SanteCompleted
-
Prem SomanAstellas Pharma US, Inc.Terminated
-
Medical University of South CarolinaAstellas Pharma US, Inc.CompletedCardiovascular Diseases | Coronary Artery DiseaseUnited States
-
Centre Jean PerrinRoche Pharma AG; NanoString Technologies, Inc.Terminated
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedCarcinoma, Non-small-cell LungCanada, United States, Australia, Singapore, Israel, China, Argentina, Germany, Sweden, Brazil, Chile, Greece, Mexico, New Zealand, Romania, South Africa, Thailand
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
OSI PharmaceuticalsNational Cancer Institute (NCI)CompletedPancreatic Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Oregon Health and Science UniversityAstellas Pharma US, Inc.Completed
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedTriglycerides | LDL CholesterolCanada
-
Princess Maxima Center for Pediatric OncologyEUSA Pharma, Inc.Not yet recruitingNeuroblastomaNetherlands
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingSolid Tumor | NeuroblastomaChina
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingAdvanced Solid Tumor | LiposarcomaChina
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEsophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Malignant Pleural Mesothelioma | Advanced Solid CancerChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedAlzheimer's DiseaseBelgium, Finland, Netherlands, Serbia, Sweden
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Regeneron PharmaceuticalsActive, not recruiting
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedParkinson's DiseaseUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedMultiple MyelomaUnited States, Philippines, United Kingdom
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedHepatic ImpairmentUnited States
-
University of NebraskaGE Healthcare; Astellas Pharma US, Inc.CompletedCoronary Artery Disease | Myocardial Perfusion AbnormalitiesUnited States
-
Jacob Soumerai, MDMEI Pharma, Inc.WithdrawnRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedHematologic Malignancy | Myeloproliferative DisorderUnited States
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.TerminatedSmall Cell Lung Cancer and Other Solid TumorsChina
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedEGFR-Mutant Lung CancerUnited States
-
University of Illinois at ChicagoAstellas Pharma US, Inc.CompletedKidney TransplantationUnited States
-
Washington University School of MedicineAstellas Pharma US, Inc.CompletedIschemic Heart DiseaseUnited States
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedHealthy VolunteersCanada
-
Edwin WuAstellas Pharma Global Development, Inc.TerminatedMyocardial Infarction | Ischemic Heart DiseaseUnited States
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.Withdrawn
-
Merck Sharp & Dohme LLCCentocor, Inc.; Essex Pharma GmbHCompleted
-
Hospital Universitario Ramon y CajalNovartis; Astellas Pharma IncUnknown
-
University of Texas Southwestern Medical CenterAstellas Pharma IncNot yet recruiting
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.Not yet recruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Klus Pharma Inc.Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina, Spain, Turkey, Georgia, Korea, Republic of, Australia, Romania